Amritsar Medical Superspeciality Institute Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Amritsar Medical Superspeciality Institute
Amritsar Medical Superspeciality Institute Private Limited (AMSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 August 2005 and has a history of 19 years and five months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayant Chawla and Neelu Nagpal serve as directors at the Company.
Company Details
-
LocationPunjab, Punjab
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110PB2005PTC028766
-
Company No.
028766
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Aug 2005
-
Date of AGM
16 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Amritsar Medical Superspeciality Institute?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Chawla
|
Director | 04-Aug-2005 | Current |
|
Neelu Nagpal
|
Director | 08-Sep-2022 | Current |
Financial Performance of Amritsar Medical Superspeciality Institute.
Amritsar Medical Superspeciality Institute Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amritsar Medical Superspeciality Institute?
In 2017, Amritsar Medical Superspeciality Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
K D Ganesha Hospital Private LimitedJayant Chawla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amritsar Medical Superspeciality Institute?
Unlock and access historical data on people associated with Amritsar Medical Superspeciality Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amritsar Medical Superspeciality Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amritsar Medical Superspeciality Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
